Ionis Pharma (NASDAQ: IONS) reported Q2 EPS of ($0.09), versus ($0.47) reported last year. Revenue for the quarter came in at $104.2 million, versus $38.5 million reported last year.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.